AI Verdict
FCRX has stronger fundamentals based on our AI analysis.
FDMT vs FCRX Fundamental Comparison
| Metric | FDMT | FCRX |
|---|---|---|
| Revenue | $85.2M | N/A |
| Net Income | $-140.1M | $34.5M |
| Net Margin | -164.4% | N/A |
| ROE | -27.7% | 4.9% |
| ROA | -24.7% | 2.1% |
| Current Ratio | 9.39x | N/A |
| Debt/Equity | 0.00x | 1.24x |
| EPS | $-2.42 | $1.81 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
FDMT vs FCRX: Frequently Asked Questions
Is FDMT or FCRX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), FCRX has stronger fundamentals. FDMT is rated STRONG SELL (92% confidence) while FCRX is rated SELL (75% confidence). This is not investment advice.
How does FDMT compare to FCRX fundamentally?
4D Molecular Therapeutics, Inc. has ROE of -27.7% vs Crescent Capital BDC, Inc.'s 4.9%. Net margins are -164.4% vs N/A respectively.
Which stock pays higher dividends, FDMT or FCRX?
FDMT has a dividend yield of N/A or no dividend while FCRX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in FDMT or FCRX for long term?
For long-term investing, consider that FDMT has STRONG SELL rating with 92% confidence, while FCRX has SELL rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about FDMT vs FCRX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For FDMT vs FCRX, the AI consensus favors FCRX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.